CLINICAL APPLICATION

5 million
annual new cases of
atrial fibrillation worldwide.

Atrial Fibrillation

Atrial fibrillation, which can also be referred to as AF or AFib, is a common condition in which the upper chambers of the heart beat rapidly in an uncontrolled manner. The irregular beating affects blood flow and may result in a fluttering feeling in the patient’s chest. The disease is associated with an increased risk of heart failure, dementia and stroke. If medications are not effective in controlling atrial fibrillation, a physician may recommend catheter ablation. Ablation is a non-surgical technique that uses imaging and monitoring systems to deploy catheters in the heart. The physician is then able to locate the electrical abnormality, deliver various forms of energy to the affected area, and check to determine if the arrhythmia has been isolated.

Normal

Atrial Fibrillation

The Vytronus Procedure – Do it Once, Do it Right

SCAN

Automated, precise 3D Maps

Real-time, high resolution anatomic maps with over 15,000 data points that adapt as the physician moves the catheter.

app-video1
app-video2

PLAN

Define the lesion path and optimal dose

Get into right position for desired lesion path. System calculates optimal dose which the EP physician may adjust.

ABLATE

Create any type of lesion

Automated lesion delivery anywhere the catheter can “see”.

app-video3
app-video4

CONFIRM

Verify electrical isolation

Confirm electrical isolation or identify touch-up ablation if necessary.

Low-Intensity Collimated Ultrasound

Vytronus offers the only AFib treatment option which uses Low-Intensity Collimated Ultrasound (LICU®). LICU® inherently does not require catheter contact with the tissue to image and ablate. Using a computer-controlled catheter tip, the Vytronus LICU® system can precisely generate high-resolution anatomical images as well as characterize the underlying tissue. Using the same catheter, the system can also deliver ultrasound energy for therapy along a user-specified lesion path.

app-video5

Publications

WHITEPAPERS & OTHERS

MedTech STRATEGIST : January 2019

Vytronus Poised to Offer the First Personalized Therapy Approach to Cardiac Ablation

Download PDF